Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liposomal Lactoferrin is a formulation that utilizes advanced liposomal technology to enhance the bioavailability and effectiveness of lactoferrin, a natural iron-binding glycoprotein that belongs to the transferrin family. This white to off-white powder has a molecular weight of approximately 80 kDa and is abundantly present in mammalian exocrine fluids such as breast milk, tears, and saliva[4][8]. The mechanism of action of Liposomal Lactoferrin is multifaceted: 1. It secures iron, preventing the growth of pathogens 2. It lowers inflammation and controls immunological responses 3. It increases the function of immune cells 4. It blocks viral entry by interacting with heparan sulfate proteoglycans (HSPGs)[1][7] The liposomal encapsulation significantly enhances transport and increases the drug's efficacy against infections, inflammation, and provides immunological support[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Liposomal Lactoferrin.